86.90.E - Healthcare
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
58.11.Z - Publishing of books
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | 0 | 0,3 | 2397,3 |
Gross profit (loss) | 0,1 | -0 | 0,3 | 1681,9 |
EBITDA | 0,2 | 0 | 0,4 | 1370,2 |
Short time liabilities | 0,3 | 0,3 | 0,2 | -24,8 |
Other operating costs | 0 | 0,1 | 0 | -57,3 |
Equity capital | 0,5 | 0,3 | 0,7 | 91,7 |
Operating profit (EBIT) | 0,1 | -0 | 0,3 | 1685,6 |
Assets | 0,8 | 0,7 | 0,9 | 34,3 |
Net profit (loss) | 0,1 | -0 | 0,3 | 1569,1 |
Cash | 0,1 | 0 | 0,2 | 1292,3 |
Net income from sale | 4,1 | 4,5 | 5,7 | 27 |
Liabilities and provisions for liabilities | 0,3 | 0,3 | 0,3 | -21,9 |
Working assets | 0,7 | 0,6 | 0,8 | 35,6 |
Other income costs | 0,2 | 0 | 0 | 35,2 |
Depreciation | 0 | 0 | 0,1 | 12,2 |
% | % | % | p.p. | |
Profitability of capital | 29,2 | -6,2 | 47,8 | 54 |
Equity capital to total assets | 60 | 49,4 | 70,6 | 21,2 |
Gross profit margin | 3,3 | -0,5 | 5,9 | 6,4 |
EBITDA Margin | 3,8 | 0,6 | 6,8 | 6,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 25 | 15 | -10 |
Current financial liquidity indicator | 2.3934664726257324 | 2.0108275413513184 | 3.6237545013427734 | 1,6 |
Net dept to EBITDA | -0.393627405166626 | 0.08349146693944931 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane